WinstonWınston
Back
Bruker Corporation logo

Bruker Corporation

BRKR
26
Medical - Devices · Healthcare
Exchange
NASDAQ
Winston Score
26
Winston is worried
Below-average fundamentals — multiple weak pillars.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Weak
Growth
Weak
Cash Flow
Weak
Stability
Good
Valuation
Data not available
Dividends
Weak

Winston Score History

The full picture

Bruker Corporation makes high-tech scientific instruments used by researchers and scientists around the world. Its main products include machines that analyze the structure of molecules, materials, and biological samples — tools like mass spectrometers, nuclear magnetic resonance (NMR) systems, and X-ray instruments. Customers include universities, pharmaceutical companies, biotech firms, and government research labs.

Bruker earns money by selling these instruments outright and through service contracts, software licenses, and consumables that customers need to keep the machines running. The company operates globally, with a strong presence in Europe, North America, and Asia, and generates roughly $3 billion in annual revenue. Its moat comes from highly specialized technology and deep customer relationships, since switching to a competitor's instruments is costly and disruptive. The key risk is that research budgets at universities and government labs can shrink during economic downturns or funding cuts, which would directly reduce demand for Bruker's expensive equipment.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+5.2% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

-920.0% YoY

YoY Growth Rate

Earnings declining

Insider Activity

32.0%ownership

Flat

Insider ownership roughly steady over the past year

Cash Runway

~5 months

$185M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Short runway — potential dilution ahead through share issuance

Cash watch

Bruker Corporation has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
49.6%
Healthy — 49.6% gross margin
Profit after running costs
Operating Margin
-7.8%
Losing money on operations — -7.8%
Return on the money invested
ROCE
2.9%
Weak — 2.9% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+1.6%
Nearly flat sales (+1.6% YoY)
Profit growth
EPS YoY
-234.4%
Earnings shrinking (-234.4% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is
EPS Consistency
1/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
Data not available
Spare cash per sale
FCF Margin
2.7%
Thin free cash flow (2.7%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.80
Moderate — manageable debt (0.80)
Covers its interest
Interest Cover
2.89x
Tight — interest eats into profit (2.9x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
no trend
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
0.31%
no trend
Small dividend — 0.31% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record
Dividend Growth
+0.0%
no trend
Dividend flat

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial